Geode Capital Management
OM icon

Geode Capital Management’s Outset Medical OM Stock Holding History

Geode Capital Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$885K Sell
204,652
-216,721
-51% -$948K ﹤0.01% 3400
2026
Q1 		$1.62M Buy
421,373
+21,010
+5% +$86.1K ﹤0.01% 3206
2025
Q4 		$1.49M Buy
400,363
+3,104
+0.8% +$26.6K ﹤0.01% 3259
2025
Q3 		$5.61M Sell
397,259
-18,293
-4% -$285K ﹤0.01% 2722
2025
Q2 		$7.98M Buy
415,552
+376,196
+956% +$5.87M ﹤0.01% 2489
2025
Q1 		$436K Buy
39,356
+1,772
+5% +$21.1K ﹤0.01% 3596
2024
Q4 		$626K Sell
37,584
-347
-0.9% -$4.33K ﹤0.01% 3539
2024
Q3 		$385K Sell
37,931
-584
-2% -$17.4K ﹤0.01% 3692
2024
Q2 		$2.23M Sell
38,515
-34,967
-48% -$1.71M ﹤0.01% 3098
2024
Q1 		$2.45M Buy
73,482
+1,698
+2% +$86K ﹤0.01% 3039
2023
Q4 		$5.83M Buy
71,784
+4,359
+6% +$355K ﹤0.01% 2625
2023
Q3 		$11M Buy
67,425
+2,499
+4% +$590K ﹤0.01% 2208
2023
Q2 		$21.3M Buy
64,926
+3,553
+6% +$1.08M ﹤0.01% 1811
2023
Q1 		$16.9M Buy
61,373
+2,341
+4% +$859K ﹤0.01% 1913
2022
Q4 		$22.9M Buy
59,032
+1,393
+2% +$393K ﹤0.01% 1678
2022
Q3 		$13.8M Buy
57,639
+4,835
+9% +$1.29M ﹤0.01% 2010
2022
Q2 		$11.8M Buy
52,804
+172
+0.3% +$74K ﹤0.01% 2136
2022
Q1 		$35.8M Buy
52,632
+1,599
+3% +$962K ﹤0.01% 1488
2021
Q4 		$35.3M Buy
51,033
+2,349
+5% +$1.74M ﹤0.01% 1572
2021
Q3 		$36.1M Buy
48,684
+11,425
+31% +$7.79M ﹤0.01% 1547
2021
Q2 		$27.9M Buy
37,259
+21,937
+143% +$16.8M ﹤0.01% 1742
2021
Q1 		$12.5M Buy
15,322
+487
+3% +$376K ﹤0.01% 2207
2020
Q4 		$12.6M Buy
14,835
+12,979
+699% +$10M ﹤0.01% 2004
2020
Q3 		$1.39M Buy
+1,856
New +$1.52M ﹤0.01% 3074

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management's OM Position: Q2 2026 in Review

Geode Capital Management reduced its Outset Medical (OM) stake by 51% in Q2 2026, selling an estimated $948K and leaving 204,652 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #3400.

Geode Capital Management first reported a position in OM in Q3 2020 and has held it in 24 quarters since. The position peaked at $36.1M in Q3 2021. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Geode Capital Management held 204,652 shares of Outset Medical worth $885K as of Q2 2026.
  • Geode Capital Management sold 216,721 Outset Medical shares in Q2 2026, an estimated $948K.
  • Outset Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3400 holding.
  • Geode Capital Management first reported a position in Outset Medical in Q3 2020 and has held it in 24 quarters since.
  • Geode Capital Management's Outset Medical position peaked at $36.1M in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.